|
RNCOS Releases a New Report- Global Cancer Treatment Forecast to 2012
RNCOS has recently added a new Market Research Report titled, "Global
Cancer Treatment Forecast to 2012" to its report gallery. This report is
a comprehensive study on the global cancer market and gives statistics
and analysis on cancer prevalence, market size, market structure, key
drug segments, market share of key players and drugs, major opportunity
areas and trends in technology development. Both the past and current
market trends have been covered in the report along the factors that are
expected to impact the market in future. This report provides answers to
a number of questions vital for firms looking for making an investment
into the sector.
Other than this, the shooting rate of Internet adoption across the world
and rising threats on Internet (like malware, spam and hack attacks) are
bolstering the demand for IT security solutions. Moreover, IT security
attacks are becoming increasingly sophisticated, requiring continuous
monitoring and updating the existing IT security solutions.
High number of unmet needs and an ever-increasing prevalence of cancer
has created a gold rush among drug companies to enter the cancer market.
Here, launching a drug successfully is risky, however, if launched,
commercial gains completely surpass the expenditures incurred.
Cancer represents the fastest growing therapy segment in the
pharmaceutical market. This segment has become the centre of focus for
drug firms and investors, and has garnered more attention than any other
therapy segment; nearly every mid-size and large pharmaceutical/biotech
company today is linked to a cancer pipeline.
Drugs available in the market today do give some respite to patients but
fail to address a numb er of complications. So manufacturers are working
to solve the problem and in future, we may see a number of drug launches
which will significantly reduce the complications and increase life
expectancy significantly.
Key Findings
- From more than 12 Million newly diagnosed cancer cases in 2007, the
number of newly diagnosed global cancer cases is expected to reach over
17 Million by 2020.
- Growing at a CAGR of 12.3% between 2007 and 2012, the global market
for cancer drugs is expected to cross US$ 78 Billion by 2012.
- Cancer vaccines and antiangiogenics will record the fastest growth
rate between 2007 and 2012.
- Drug manufactures are now focused on developing target therapies.
These drugs attack target cells and thus limit the severity of side
effects.
- The US is the largest market for cancer drugs, followed by Europe and
Japan.
- Drugs for cancer represent the largest therapy area under clinical
development; however, when it comes to approval rates, drugs for cancer
have the worst approval rates.
Key Issues Analyzed
- Evaluation of past, current and future market trends.
- Discussion on major cancer drugs and their markets.
- Future forecast of the cancer market.
- Analysis of various challenges and opportunities for the industry.
- Categories of players operating in the market and their present and
future revenue forecast.
- Analysis of key Geographical markets.
Research Methodology Used
Information Sources
The information given in the report has been sourced from various
credible sources like books, newspapers, trade journals, white papers,
industry portals, government agencies, trade associations, monitoring
industry news and developments, and through access to over 3000 paid
databases.
Analysis Methods
The analysis methods used in the report include ratio analysis,
historical trend analysis, linear regression analysis using software
tools, judgmental forecasting, and cause and effect analysis .
About RNCOS:
RNCOS, incorporated in the year 2002, is an industry research firm. We
are a team of industry experts who analyze data collected from credible
sources. We provide industry insights and analysis that helps
corporations to take timely and accurate business decision in today's
globally competitive environment.
For more information visit: http://rncos.com/Report/IM130.htm
Current Industry News: http://www.rncos.com/Blog/
Disclaimer: The views and opinions expressed in the research published are those of the individual companies and writers and not necessarily those of Investorideas.com®, or any of the industry sector portals . At the time of publication, writers may hold positions in the stocks or companies mentioned.
Investorideas.com® or any of the industry sector portals cannot assure accuracy of the research presented. Investors are encouraged to research and verify facts and under no circumstances is Investorideas.com® endorsing the content as a recommendation to buy or sell stock.
Would you like to see your news and articles here? GO>>
|
